ADIM
IGSB icon

Alpha DNA Investment Management’s iShares 1-5 Year Investment Grade Corporate Bond ETF IGSB Stock Holding History

Alpha DNA Investment Management’s Portfolio IGSB Stock Details IGSB Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q2 		– Sell
-246
Closed -$13K – 348
2021
Q1 		$13K Buy
246
+173
+237% +$9.5K 0.01% 276
2020
Q4 		$4K Buy
+73
New +$4.01K ﹤0.01% 396

Other funds holding IGSB

Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $374B AUM 17.66% 1-Year Est. Return
Charles Schwab
Charles Schwab San Francisco, California $654B AUM 26.35% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
MMI
Matson Money Inc Mason, Ohio $3.59B AUM 16.37% 1-Year Est. Return
Members Trust
Members Trust Tampa, Florida $3.01B AUM 10.24% 1-Year Est. Return
FRBONY
Federal Reserve Bank of New York New York $5.06B AUM
MYLI
Meiji Yasuda Life Insurance Tokyo, Japan $2.93B AUM 4.27% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Alpha DNA Investment Management's IGSB Position: Q2 2021 in Review

Alpha DNA Investment Management sold out of iShares 1-5 Year Investment Grade Corporate Bond ETF (IGSB) in Q2 2021, closing a stake of 246 shares — an estimated $13K sold.

Alpha DNA Investment Management first reported a position in IGSB in Q4 2020 and held it in 2 quarters. The position peaked at $13K in Q1 2021. 903 funds tracked by Wall St. Rank hold IGSB as of Q2 2021.

  • Alpha DNA Investment Management reported no remaining iShares 1-5 Year Investment Grade Corporate Bond ETF position as of Q2 2021 after selling out during the quarter.
  • Alpha DNA Investment Management sold 246 iShares 1-5 Year Investment Grade Corporate Bond ETF shares in Q2 2021, an estimated $13K.
  • Alpha DNA Investment Management first reported a position in iShares 1-5 Year Investment Grade Corporate Bond ETF in Q4 2020 and held it in 2 quarters.
  • Alpha DNA Investment Management's iShares 1-5 Year Investment Grade Corporate Bond ETF position peaked at $13K in Q1 2021.
  • 903 funds tracked by Wall St. Rank held iShares 1-5 Year Investment Grade Corporate Bond ETF as of Q2 2021.

Based on Alpha DNA Investment Management's 13F filing for Q2 2021, filed 10 Aug 2021.